Triple-negative breast cancer (TNBC) is referred to as a subtype of breast cancer that lacks estrogen receptor (ER), progesterone receptor (PR) expression, and human epidermal growth factor receptor 2 (HER-2) expression/amplification. Here, ESR1 is linked to triple-negative breast carcinoma.